INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🟢 Indaptus Therapeutics is trading 6.19% up today after announcing amended $100 million at-the-market offering
On September 2, 2026, Indaptus Therapeutics is trading at $1.20, up +6.19%, after announcing an amended and restated at-the-market offering allowing up to $100...
🟢 Indaptus Therapeutics is trading 6% up in after-hours trading after launching amended $100 million equity offering
Indaptus Therapeutics is trading at $1.20, up 6.19% in after-hours trading after launching an amended $100 million at-the-market equity offering through H.C....
Indaptus Therapeutics Launches $100M Offering, Addressing Going Concern Risks
Indaptus Therapeutics established an at-the-market (ATM) equity program to sell up to $100 million of common stock. H.C. Wainwright & Co. will manage the sales...
🔴 Indaptus Therapeutics is trading 5.17% down today as XBI falls 2.31%
Indaptus Therapeutics is trading 5.17% down now at $1.10 amid weakness across biotechnology stocks. - XBI, the sector ETF, is down 2.31% during regular...
🟢 Indaptus Therapeutics is trading 7% up today amid broader market gains
Indaptus Therapeutics is trading 7.02% up now at $1.22, supported by the Nasdaq rising 1.34% and S&P 500 gaining 0.59%. - No new company-specific announcement...
🔴 Indaptus Therapeutics is trading 5.18% down today amid a 58,895,000-share resale registration
Indaptus Therapeutics is trading 5.18% down at $1.10 amid continued volatility and supply concerns following its August 20, 2026 surge. - An August 17 SEC...
🟢 Indaptus Therapeutics is trading 8% up in pre-market amid Nasdaq futures rising 0.85%
Indaptus Therapeutics is trading 7.97% up at $1.25, possibly reflecting firmer pre-market sentiment as Nasdaq futures rise 0.85%. - A volatile stretch...
🔴 Indaptus Therapeutics is trading 10.86% down today after continued profit-taking
Indaptus Therapeutics is trading 10.86% down at $1.15 after continued profit-taking following its 46.81% surge on August 20 and 6.52% decline on August 21. -...
🔴 Indaptus Therapeutics is trading 6.96% down in pre-market amid biotech-sector weakness and reduced momentum
Indaptus Therapeutics is trading 6.96% down at $1.20 after continued profit-taking following its 46.81% surge on August 20 and 6.52% decline on August 21. -...
🔴 Indaptus Therapeutics is trading 11.59% down today on profit-taking and broader biotech-sector weakness
Indaptus Therapeutics is trading 11.59% down at $1.22, apparently due to profit-taking and broader biotech-sector weakness rather than a new company-specific...
🔴 Indaptus Therapeutics is trading 7.97% down today after profit-taking following the prior session’s sharp advance
Indaptus Therapeutics is trading 7.97% down at $1.27, primarily amid biotech-sector weakness and profit-taking after the prior session’s sharp advance. -...
🔴 Indaptus Therapeutics is trading 6.52% down in pre-market after a 46.81% prior-session surge
Indaptus Therapeutics is trading $1.29 (-6.52%) after a sharp 46.81% advance to $1.38 on August 20. - No major August 21 company announcement or overnight...
🟢 Indaptus Therapeutics is trading 26.39% up today with no clear catalyst identified
Indaptus Therapeutics is trading 26.39% up at $1.19, with no clear company-specific catalyst identified for August 20, 2026. - Latest notable disclosures were...
🟢 Indaptus Therapeutics is trading 6% up today with no clear catalyst identified
Indaptus Therapeutics is trading 5.97% up at $1.00, with no fresh company-specific announcement identified on August 20, 2026. - Latest notable disclosures...
🟢 Indaptus Therapeutics is trading 11.1% up today as Moderna’s positive cancer-vaccine results lift biotech
Indaptus Therapeutics is trading 11.1% up at $1.04, outperforming the broader market as biotechnology sentiment improves following Moderna’s positive...
Indaptus Therapeutics Files 59M Share Resale Amid Going-Concern Warning
Indaptus Therapeutics filed for a secondary offering of up to 58,895,000 common shares by selling stockholders. The company will not sell any shares or receive...
🔴 Indaptus Therapeutics is trading 5.66% down today as risk-off sentiment weighs on markets
Indaptus Therapeutics is trading 5.66% down now at $0.94, with the decline appearing aligned with broader risk-off sentiment. - Shares fell 6.54% to $1.00 on...
🟢 Indaptus Therapeutics is trading 5.33% up in pre-market despite no clearly reported company-specific announcement
Indaptus Therapeutics is trading 5.33% up at $1.05 despite no clearly reported company-specific announcement on August 18, 2026. - The latest identifiable...
🟢 Indaptus Therapeutics is trading 5% up in after-hours trading
Indaptus Therapeutics is trading 5% up at $1.05 in after-hours trading after closing at $1.00 on August 17, 2026; no major company-specific announcement tied...
🔴 Indaptus Therapeutics is trading 8.4% down today after Decoy20 trial discontinuation
Indaptus Therapeutics is trading at $0.98 (-8.40%) on August 17, 2026, following its August 13 second-quarter report and corporate update, alongside the...